Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5600
-0.0400 (-6.67%)
Mar 4, 2026, 4:00 PM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
5.45M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 146 | -21 | -12.57% | 146 | 0 |
| Dec 31, 2022 | 167 | 16 | 10.60% | 167 | 0 |
| Dec 31, 2021 | 151 | 40 | 36.04% | 151 | 0 |
| Dec 31, 2020 | 111 | -198 | -64.08% | 111 | 0 |
| Dec 31, 2019 | 309 | 78 | 33.77% | 309 | 0 |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| May 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Brainstorm Cell Therapeutics | 23 |
| Mosaic ImmunoEngineering | 8 |
| Bioxytran | 3 |
| AccuStem Sciences | 2 |
| Synlogic | 1 |
Orgenesis News
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 1 year ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 years ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 2 years ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire
- 2 years ago - Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference - GlobeNewsWire